Caplin Point Laboratories has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company at their meeting held today, December 15, 2022, has allotted 91,704 equity shares of face value Rs 2 each, to the employees of the Company and its subsidiaries, upon exercise of stock options under Employee Stock Options Scheme 2017.
The above information is a part of company’s filings submitted to BSE.